首页> 外文期刊>International ophthalmology >Vogt-Koyanagi-Harada disease occurring during interferon-alpha and ribavirin therapy for chronic hepatitis C virus infection.
【24h】

Vogt-Koyanagi-Harada disease occurring during interferon-alpha and ribavirin therapy for chronic hepatitis C virus infection.

机译:Vogt-Koyanagi-Harada病在慢性丙型肝炎病毒感染的干扰素-α和病毒唑治疗期间发生。

获取原文
获取原文并翻译 | 示例
           

摘要

We report a case of Vogt-Koyanagi-Harada (VKH) disease in a 30-year-old patient who was receiving interferon-alpha and ribavirin therapy for chronic hepatitis C virus infection. The intraocular inflammation responded to systemic corticosteroid and mycophenolate mofetil treatment. Physicians should be aware of the association between interferon-alpha and ribavirin therapy for hepatitis C virus infection and the development of VKH disease.
机译:我们报告了一名30岁患者中正在接受干扰素-α和利巴韦林治疗慢性丙型肝炎病毒感染的Vogt-Koyanagi-Harada(VKH)病病例。眼内炎症对全身性皮质类固醇激素和霉酚酸酯的治疗有反应。医师应意识到用于丙型肝炎病毒感染的干扰素-α和利巴韦林疗法与VKH病发展之间的关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号